Alexandra Vacaru

Ms. Alexandra Vacaru

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2023 in Urology Practice
Verified
Journal Article
Closed access
MHMohammad Hajiha
Mohammad Hajiha
DLDonna Lien
Donna Lien
JJJo Ann Johnson
Jo Ann Johnson
IMIvan Muchiutti
Ivan Muchiutti
JSJasmine Sran
Jasmine Sran
HRHerbert Ruckle
Herbert Ruckle
Introduction:This study investigated the effectiveness of buprenorphine as an alternative to the use of conventional opioids perioperatively in an effort to help mitigate the impact of the use of perioperative conventional opioids for patients undergoing robotic-assisted laparoscopic prostatectomy.Methods:Outcomes of patients with localized prostate cancer undergoing robotic-assisted laparoscopic prostatectomy were examined before and after implementation of novel quality improvement study that included receiving buprenorphine compared to conventional opioids for pain control intraoperatively and postoperatively. The primary end point was adequate pain control with secondary end points being analgesic consumption at home, opioid-related side effects, and patient satisfaction.Results:When analyzing the secondary end point of oral morphine milligram equivalents, the buprenorphine group received significantly less morphine milligram equivalent compared to the conventional opioid group (15.19 vs 47.91, P = .006). The buprenorphine group also had lower reported pain scores at discharge (4.3; scale 1-10) compared to the conventional opioid group (5.4), though this did not reach significance (P = .069). In the buprenorphine group, 76.9% strongly agreed that their pain was adequately controlled in the hospital compared to 57.5% of the conventional opioid group (P = .223). There was no difference in overall satisfaction at postoperative day 5 (P = .358).Conclusions:Our study demonstrates buprenorphine's analgesic capabilities to maintain adequate pain control and patient satisfaction compared to conventional opioids during robotic-assisted laparoscopic prostatectomy, while decreasing perioperative opioid use.

19 February 2026 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
JMJoyce J.L.H. McRae
Joyce J.L.H. McRae
SRSteven Raymond
Steven Raymond
GMGeorgi Mladenov
Georgi Mladenov
MKMark Kashtan
Mark Kashtan
ESEmily Stevenson
Emily Stevenson
ETEdward P. Tagge
Edward P. Tagge
The incidence of pediatric gallstone disease continues to rise, largely driven by increasing obesity rates. Laparoscopic cholecystectomy (LC) has been the standard surgical approach, with robotic-assisted cholecystectomy (RAC) utilized less frequently. This study aimed to evaluate the implementation of RAC and its outcomes compared to LC at a single institution. A retrospective cohort study was conducted of all pediatric cholecystectomies at our children's hospital from 2017 through 2024. Surgical outcomes were abstracted. Statistical tests were employed, with p < 0.05 considered significant. During the study, 420 cholecystectomies were performed: 196 LC and 224 RAC. Median age was 15.5 years, median BMI was 28.1 kg/m2, and 75 % of patients were female. The most common diagnoses were choledocholithiasis (179) and symptomatic cholelithiasis (135). Yearly cholecystectomies increased. LC was performed more often for urgent cases (p < 0.01). RAC was used more often in patients with obesity and severe obesity (p = 0.01). Median operative time slightly differed between LC and RAC (11 min; p < 0.01). There was one conversion to open (LC) and nine retained common duct stones. There was no difference in emergency department revisits (7.7 % LC vs 6.7 % RAC; p = 0.69) or readmissions (2.6 % LC vs 3.1 % RAC; p = 0.73). There were no bile leaks, common bile duct injuries or mortalities. In this largest reported cohort of pediatric RAC, RAC was found to be safe and effective compared with LC, particularly in pediatric patients with obesity. RAC can be integrated into practice without compromising patient safety. Further research evaluating educational and fiscal aspects of RAC is ongoing.

21 June 2024 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
NPNihal Punjabi
Nihal Punjabi
AVAlexandra Vacaru
Alexandra Vacaru
IAIzabelle C. Azar
Izabelle C. Azar
Objective: To qualitatively describe variation in morphology of the genial tubercle and quantify the spatial relationship between the tubercle and genioglossus muscle. Study Design: Case series. Setting: Cadaver dissection. Methods: Segmental sections of the mandible, with muscular attachments intact, were harvested from 18 fresh cadaver heads. Three‐dimensional laser scans, with a resolution of 0.025 mm, were taken of each specimen with muscle attached and repeated after muscle removal. The genioglossus muscular attachment was measured relation to bony landmarks. Results: The morphology of the genial tubercle varied, with anywhere from 1 large spine to 4 individual spines. However, all specimens had a distinguishable superior portion of the tubercle, where the genioglossus attached, and an inferior portion, where the geniohyoid attached. The height of the superior tubercle (ST) was 6.1 mm (95% confidence inerval [CI]: 5.7‐6.5). The height of the genioglossus muscle above the peak amplitude of the ST was 4.3 mm (3.8‐4.9), but only 2.5 mm (2.0‐3.0) below. On average, 64.4% (58.6‐70.2) of the height of the genioglossus muscle attachment was above the peak. Overall, 19.5% (14.1‐25.0) of the muscle surface area extended beyond the boundaries of the tubercle. Conclusion: The genioglossus muscle attachment originates from the superior genial tubercle, which has a variable topography and amplitude. However, the muscle is not centered on the spines–more of the muscular fibers attach above the spine as compared to below. This new data may explain the genioglossus advancement “miss rate”–failure to advance muscle on initial osteotomy–of 39‐78% reported in the literature.

1 March 2024 in Surgical Neurology International
Verified
Journal Article
Open access
TWTaylor Anne Wilson
Taylor Anne Wilson
JJJoseph I. Kang Jr
Joseph I. Kang Jr
LHLei Huang
Lei Huang
AVAlexandra Vacaru
Alexandra Vacaru
KMKevin Nogueira Martins
Kevin Nogueira Martins
WBWarren Boling
Warren Boling
The World Health Organization (WHO) grade 2 meningiomas behave aggressively with a high proclivity toward recurrence despite maximal surgical resection. Our institution, a pioneer of proton therapy, uses exclusively proton beam radiation, and thus, we present a retrospective cohort analysis of patients with WHO grade 2 meningiomas treated with adjuvant proton beam therapy (PBT) at our institution between 2007 and 2019. The effects of adjuvant PBT were evaluated. Data collected include diagnosis, gender, histological subtype, WHO grade, the extent of surgical resection, adjuvant PBT radiation, details of the PBT radiation, recurrence, any additional PBT radiation, systemic medical therapy, and disease-specific survival. Among the WHO grade 2 meningiomas (n = 50) recommended PBT, 80% and 78% of patients with gross-total resection (GTR) and subtotal resection (STR), respectively, followed through with PBT. The median radiation dose of PBT was 59.5 Gy and 59.92 Gy for patients with GTR and STR, respectively, with a median of 33 fractions delivered in 1.8 Gy doses for both groups. Combined 3-year progression-free survival (PFS) was 96%, and 5-year PFS was 92%. Combined overall survival was 95% at five years. Minimal radiation side effects were reported with no grade 3 or higher toxicities. Our results suggest that adjuvant PBT is well tolerated with minimal radiation toxicity. Alternative to photon radiation, PBT may be considered at least as safe and effective for adjuvant treatment of WHO grade 2 meningiomas when it is available.

17 February 2026 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
AVAlexandra Vacaru
Alexandra Vacaru
RQRoy Wang Qu
Roy Wang Qu
JHJacob Hauser
Jacob Hauser
TWTraeden Wilson
Traeden Wilson
EYEverett Young
Everett Young
JIJared C. Inman
Jared C. Inman
Objectives: Comorbidity and frailty indices have been used to predict postoperative outcomes, but their reliability in predicting postoperative disposition to nonhome settings after head and neck free flap surgery remains unclear. To evaluate whether indices predict disposition to nonhome settings in patients undergoing head and neck free flap surgery. Methods: Retrospective cohort study of 671 patients who underwent head and neck free flap surgery between September 1, 2014, and September 1, 2024; recurrent cases were excluded. The relationships of frailty indices with postoperative disposition (home vs. nonhome settings), hospital length of stay (LOS), and intensive care unit (ICU) LOS were analyzed. Indices assessed were Charlson Comorbidity Index (CCI), American Society of Anesthesiologists (ASA) status, modified frailty index (mFI), and Washington University Head and Neck Comorbidity Index (WUHNCI). Primary outcome was postoperative disposition (discharge to home or nonhome settings). Secondary outcomes included hospital and ICU LOS. Results: Mean age was 64 ± 16 years, with 63% discharged home. Higher index scores were associated with nonhome disposition ( p < 0.001), with the CCI showing the strongest predictive performance (AUC = 0.682). Indices were also associated with longer hospital and ICU LOS, while age alone was not predictive. Conclusion: Indices, particularly the CCI, predict discharge disposition and LOS after head and neck free flap surgery. These indices may aid clinicians in counseling patients and families during preoperative planning. Level of Evidence: 3

2 June 2023 in Journal of Pediatric Surgery Case Reports
Verified
Journal Article
Open access
AVAlexandra Vacaru
Alexandra Vacaru
FSFransua Sharafeddin
Fransua Sharafeddin
AMAlexandra Maidan
Alexandra Maidan
DMDonald C. Moores
Donald C. Moores
SRSteven L. Raymond
Steven L. Raymond
ARAndrei Radulescu
Andrei Radulescu